Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer
NCT06517901
This study is recruiting at 2 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
The MRI-targeted biopsy for prostate cancer detection can be performed using one of two techniques: Software-based fusion of MRI and ultrasound images (software fusion) or Visually estimated MRI-informed (cognitive fusion) technique To date, there is a lack of adequately powered RCTs directly comparing the cognitive vs fusion targeted biopsy.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Prostate Cancer
- Diagnosis
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- Male
- Healthy volunteers
- Not accepted
- Sponsor
- Albany Medical College
- Last updated on ClinicalTrials.gov
- October 3, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Massachusetts · 1
- Lahey Clinic, Inc · Burlington, MA
New York · 1
- Albany Medical Center · Albany, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.